Improving ECMO therapy with nitric oxide
Hospital Care

Improving ECMO therapy with nitric oxide

Although Extracorporeal Membrane Oxygenation (or ECMO) is a vital strategy to assist critically-ill patients survive, by providing the circulation of oxygen through the body, and is becoming an increasingly popular treatment across the globe, there are some severe complications that can arise with its use.

It has been found that during current ECMO treatments, as the patients’ blood is circulated outside of the body through the ECMO device and then pumped back into the body, the blood exposure to foreign materials and force of the blood moving through the blood vessels results in significant damage to blood cells and plasma proteins. This has also been shown to activate coagulatory (thickening of the blood) and inflammatory systems.

These complications can lead to a major reaction in the body and poor patient outcomes and a low survival rate. It is also seen that these harmful outcomes are again compounded by the current limitations in effective anti-coagulation therapies used ECMO.

The limitations of this life-saving therapy can lead to decreased confidence for its use – although it may still be the patient’s only hope. But, there is hope in some promising, yet limited, evidence indicating that nitric oxide may be an effective strategy for improved patient outcomes during and post-ECMO.

Professor John Fraser and his team are taking the challenge to investigate the potential benefits of introducing nitric oxide therapies to ECMO patients. They will be observing the abilities of nitric oxide across various markers such as its ability to: regulate blood cell and vessel geometry/activity, decreases platelet activation, regulate coagulation and its anti-oxidant properties helping to minimise inflammation.

The results of this study could change and enhance treatments for ECMO patients, greatly improve the success of ECMO and increase confidence in its use. Helping to save the lives of our most critically ill worldwide, with reduced risks.

Support The Common Good here.

Published: April 26, 2019

Related news & events

Mother-of-four shares story of transplant journey

Patient Stories

Mother-of-four shares story of transplant journey

A Queensland mother who was diagnosed with Idiopathic Pulmonary Fibrosis and Chronic Hypersensitivity Pneumonitis and later received a lung transplant, shares her story here.

Find out more

The journey from the Cycle of Giving to the Tour de Brisbane

The Common Good

The journey from the Cycle of Giving to the Tour de Brisbane

In 2006, Mary and Mal Long started an event called Cycle of Giving to show their gratitude to Mal’s donor family and medical team.

Find out more

Chain Reaction Challenge 2024: Helping Kids visiting The Prince Charles Hospital

The Common Good

Chain Reaction Challenge 2024: Helping Kids visiting The Prince Charles Hospital

In March, dozens of cyclists from Brisbane will take part in a 1000 km cycle in and around Adelaide for the Chain Reaction Challenge 2024.

Find out more

30-year-old heart transplant recipient’s journey to the 2024 Tour de Brisbane

Heart Disease

30-year-old heart transplant recipient’s journey to the 2024 Tour de Brisbane

A Perth father who received a heart transplant three years ago is preparing to take part in the 2024 Tour de Brisbane. Read more about his journey and support his ride here.

Find out more

International Day of Women and Girls in Science 2024

The Common Good

International Day of Women and Girls in Science 2024

This February, we acknowledge International Day of Women and Girls in Science 2024 and some of the remarkable women who are making a difference in STEM.

Find out more

Marfan and Aortopathy Conference Brisbane 2024

The Common Good

Marfan and Aortopathy Conference Brisbane 2024

The Marfan and Aortopathy Conference Brisbane 2024 is on Saturday, April 20, at The Prince Charles Hospital. Click here for more details.

Find out more

What is Marfan Syndrome?

The Common Good

What is Marfan Syndrome?

What is Marfan Syndrome? It affects about 1 in 5000 people across the globe, and for some, it can lead to serious or even life-threatening complications. Learn more here.

Find out more

The Café for The Common Good finds new home at Caboolture Hospital

Social Enterprise

The Café for The Common Good finds new home at Caboolture Hospital

Caboolture Hospital Café: In exciting news, our café has a new home in the hospital’s recently opened Clinical Services Building.

Find out more

Take a walk down Memory Lane at The Prince Charles Hospital

Ageing

Take a walk down Memory Lane at The Prince Charles Hospital

At The Prince Charles Hospital, patients and their families are encouraged to take a trip down the newly completed ‘Memory Lane’. Read about the impactful project here.

Find out more